KLXE heads into its May 13 print on the back of a 73% surge in one month, a move that towers over every correlated peer in the oilfield services space.
The rally's origin story sits in the insider register. The acting CFO bought 50,000 shares across two transactions in mid-December at prices between $1.85 and $1.94. The Chief Compliance Officer added 16,500 shares at $1.67 in the same week. Those buys came at or near what proved to be the stock's floor. Both insiders subsequently sold small parcels in January and February — but those disposals, at $2.58–$2.78, look more like routine year-end tax management than conviction reversals. Net insider activity over the past 90 days is positive at roughly 165,000 shares and $389,000. The directional read is clear: insiders leaned in at the low.
Short positioning has been retreating as the stock climbed. Short interest has fallen roughly 25% from its April peak and now runs at 7.2% of the free float, down 7% on the week alone. That unwinding is consistent with short sellers covering into the rally rather than adding pressure. Borrow costs remain cheap at 1.1%, and the lending pool is far from exhausted — availability is nowhere near stressed levels — so there is no mechanical squeeze dynamic forcing the covering. Shorts are simply stepping aside. The ORTEX short score of 63 (ranked in the 6th percentile of the universe) reflects a stock that still carries meaningful bearish positioning, but the trend is clearly toward de-risking.
Options are almost entirely a non-story. The put/call ratio is near its 52-week floor at 0.010, well below the 20-day mean. The options market is not pricing in serious downside risk — if anything, it leans mildly bullish heading into the print. Peers, by contrast, had a rougher week: RES dropped 9.5%, HP fell 5.7%, and PTEN lost 2.8%. KLXE's 3.5% gain on the week is a notable divergence, partly reflecting the insider-driven momentum narrative that has taken hold in the stock.
The one cautionary note is the earnings history. The most recent prior event, in early May, produced a 12.6% one-day drop. The March print also saw the stock fall nearly 9% before stabilising. Analyst coverage is thin and stale — the most recent target on file is $4.50 from Piper Sandler, set in mid-2024, and all activity from that period reflects a sustained downgrade cycle as the stock fell from double digits. That data is too dated to carry analytical weight today.
The earnings print will test whether the operational story has turned enough to justify a stock that has more than doubled from its December trough — and whether insiders who bought at the bottom were early or simply right.
See the live data behind this article on ORTEX.
Open KLXE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
